Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;174(10):1483-1487.
doi: 10.7326/M21-1375. Epub 2021 Jul 20.

Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study

Ashley Kieran Clift  1 , Defne Saatci  1 , Carol A C Coupland  2 , Hajira Dambha-Miller  3 , Julia Hippisley-Cox  1 ; International Investigator Group for Ethnicity and COVID-19
Collaborators, Affiliations

Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study

Ashley Kieran Clift et al. Ann Intern Med. 2021 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M21-1375.

Figures

Figure.
Figure.. Adjusted HRs with 95% CIs for the observed associations between sickle cell disease and sickle cell trait with COVID-19–related hospitalization and COVID-19–related death; the reference group is persons without any sickle cell disorder.
Cause-specific Cox regression models were stratified by individual general practice and adjusted for age (restricted cubic spline with 5 knots), sex, and self-reported ethnicity (White, South Asian, Black, and other [including Chinese, multiracial, and Arab]). We did post hoc analyses restricted to those with sickle cell disorders. For COVID-19–related hospitalization, compared with persons with sickle cell trait, those with sickle cell disease had an adjusted HR of 3.00 (95% CI, 1.99 to 4.52). For COVID-19–related death, persons with sickle cell disease had an adjusted HR of 1.37 (CI, 0.62 to 3.02) compared with those with sickle cell trait. HR = hazard ratio.
See this image and copyright information in PMC

References

    1. Kato GJ , Piel FB , Reid CD , et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4:18010. [PMID: ] doi:10.1038/nrdp.2018.10 - DOI - PubMed
    1. Kato GJ , Steinberg MH , Gladwin MT . Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017;127:750-760. [PMID: ] doi:10.1172/JCI89741 - DOI - PMC - PubMed
    1. McCloskey KA , Meenan J , Hall R , et al. COVID-19 infection and sickle cell disease: a UK centre experience [Letter]. Br J Haematol. 2020;190:e57-e58. [PMID: ] doi:10.1111/bjh.16779 - DOI - PubMed
    1. Panepinto JA , Brandow A , Mucalo L , et al. Coronavirus disease among persons with sickle cell disease, United States, March 20-May 21, 2020. Emerg Infect Dis. 2020;26:2473-2476. [PMID: ] doi:10.3201/eid2610.202792 - DOI - PMC - PubMed
    1. Arlet JB , de Luna G , Khimoud D , et al. Prognosis of patients with sickle cell disease and COVID-19: a French experience. Lancet Haematol. 2020;7:e632-e634. [PMID: ] doi:10.1016/S2352-3026(20)30204-0 - DOI - PMC - PubMed